Skip to main content
. Author manuscript; available in PMC: 2008 Aug 5.
Published in final edited form as: J Gerontol A Biol Sci Med Sci. 2001 Nov;56(11):M724–M730. doi: 10.1093/gerona/56.11.m724

Table 3.

Subject Characteristics and Dietary Intake

Trial

Characteristic LPro MPro HPro
Age, y 75 ± 4.0
Height, cm 64.1 ± 0.6
Weight, kg
 Week 2 72.7 ± 3.9 73.0 ± 4.0 72.8 ± 4.0
 Week 3 72.3 ± 3.9 72.8 ± 4.0 72.4 ± 4.0
Body mass index, kg/m2 27.3 ± 3.8
Body fat, %
 Week 2 44.0 ± 1.5 44.4 ± 1.5 44.3 ± 1.6
 Week 3 45.0 ± 1.6 45.2 ± 1.5 43.5 ± 1.7
Fat-free mass, kg
 Week 2 38.8 ± 1.5 40.1 ± 1.6 40.7 ± 2.0
 Week 3 39.4 ± 1.6 39.6 ± 1.6 40.1 ± 1.7
Resting metabolic rate, MJ/d 4.99 ± 0.22 4.95 ± 0.18 4.96 ± 0.17
Energy intake, MJ/d 9.31 ± 0.26 9.32 ± 0.27 9.33 ± 0.27
Carbohydrate intake, g/d 330 ± 9.5 313 ± 8.8 302 ± 8.6
Fat intake, g/d 77 ± 2.0 78 ± 2.0 74 ± 2.0
Protein intake, g/d 36.6 ± 1.8 54.9 ± 2.7 73.2 ± 3.6
 (g·kg-1·d-1) 0.50 ± 0.01 0.75 ± 2.7 1.01 ± 3.6

Notes: Values are reported as mean ± SEM. LPro refers to a measured protein intake of 0.53 ± 0.02 g of protein·kg−1·d−1; MPro refers to 0.76 ± 0.02 g of protein·kg−1·d−1; and HPro refers to 1.06 ± 0.05 g of protein·kg−1·d−1.

Percentage of body fat and fat-free mass were determined by whole body plethysmography.

Carbohydrate, fat, and protein intakes were different among trials (p < .0001).